Genome Institute of Singapore (GIS)

Scientists discover genes encoding colours, scents and bioactive compounds in the genome of Papilionanthe Miss Joaquim, Singapore’s National Flower.

Researchers have discovered a molecular pathway in colorectal cancer cells that leads to uncontrolled division, creating an avenue for more targeted therapies.

Using a new genome analysis technology, A*STAR scientists discover never-before-seen immune responses in tuberculosis infections.

Multidisciplinary efforts across A*STAR are paving the way toward Singapore’s precision medicine vision.

Through innovative molecular technologies, Jinyue Liu is building maps of the brain’s circuitry to better understand how these connections go awry in disease.

Experimental gene therapy promises a new lease of life for patients with genetic heart disease.

New gastric cancer insights come to light with the help of powerful single-cell technologies.

Cancer genetics experts say new technologies and more comprehensive data collection are required to deepen our understanding of tumour lifecycles.

By looking at Peranakan Chinese genomes, researchers confirm the community arose from genetic mixing between local Malay women and foreign Chinese traders in the past.

Using improved mouse models for gastric cancer, A*STAR scientists uncover a pool of cancer stem cells key to disease progression.

The first open-access database of mononuclear phagocytes, created by A*STAR researchers, provides insight into the biology of these immune cells and their roles in fighting disease.

Nuevocor, an A*STAR spin-off company, is designing novel therapies to target the genetic causes of heart diseases, bringing basic research to clinical impact.